Effects of a low-carbohydrate diet in adults with type 1 diabetes: an interventional study protocol

Authors

  • Jessica L. Turton Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia
  • Grant D. Brinkworth CSIRO-Health and Biosecurity, North Ryde NSW 2113, Australia
  • Helen M. Parker Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia
  • Kevin Lee Qscan Group, Clayfield QLD 4011, Australia
  • David Lim Church Street Medical Practice, Newtown NSW 2042, Australia
  • Amy Rush Type 1 Diabetes Family Centre, Stirling WA 6021, Australia
  • Rebecca Johnson Type 1 Diabetes Family Centre, Stirling WA 6021, Australia
  • Kieron B. Rooney Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia

DOI:

https://doi.org/10.18203/2349-3259.ijct20212846

Keywords:

Diabetes, Glycaemic control, Low-carbohydrate diet, Diet therapy

Abstract

Background: Type 1 diabetes (T1D) is an autoimmune condition characterised by pancreatic beta cell destruction and absolute insulin deficiency. The varying impact of dietary factors on blood glucose levels is well-known, yet there remains a lack of consensus surrounding the optimal dietary approaches to achieve glycaemic control in T1D. The aim of this research is to assess the efficacy of a low-carbohydrate (LC) diet in adults with T1D. We will set out to determine whether significant differences in T1D management outcomes exist between a LC diet and habitual diets higher in carbohydrate. Our primary hypothesis is that a LC diet will result in improved T1D management compared to habitual diets higher in carbohydrates.

Methods: This is a 28-week single arm within-participant intervention study involving a 4-week control period, a 12-week intervention period and a 12-week follow-up. We plan to recruit 20 adults (18-60 years) with T1D (duration ≥6 months) who have suboptimal glycaemic control (HbA1c>7.0%). The primary outcome is haemoglobin A1c (HbA1c) and secondary outcomes include glycaemic variability, frequency of hypoglycaemia, total daily insulin, and quality of life. This LC diet will start at 50 g of digestible carbohydrate per day and then there will be opportunity to increase or decrease within a broader range of 25-75 g/day according to individual blood glucose levels and personal preference.  Participants will meet individually with the study dietitian for a total of six fortnightly sessions to receive dietary instruction, strategies, and education. Participants will continue to work with a member of their usual diabetes care team for specific advice regarding insulin management.

Conclusions: Current dietary management strategies for T1D appear to be lacking in effect and additional dietary therapies, including LC diets, require urgent consideration. Therefore, an interventional study investigating a patient-led LC dietary approach will be of important clinical relevance for healthcare practitioners and may help to better inform clinical practice guidelines for T1D management.

Trial Registration: https://www.anzctr.org.au/ACTRN12621000764831.aspx

Author Biographies

Jessica L. Turton, Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia

Faculty of Medicine and Health

Grant D. Brinkworth, CSIRO-Health and Biosecurity, North Ryde NSW 2113, Australia

Health and Biosecurity

Helen M. Parker, Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia

Faculty of Medicine and Health

Kieron B. Rooney, Department of Exercise and Sports Science, Faculty of Medicine and Health, The University of Sydney, Camperdown NSW 2006, Australia

Faculty of Medicine and Health

References

Craig M, Twigg S, Donaghue K. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. 2011.

Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017;7:e015949.

Kelly CT, Mansoor J, Dohm GL. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think. Surgery. 2014;156:405-11.

Wang MY, Yu X, Lee Y. Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers. J diabetes its complications. 2013;27:70-74.

McKnight JA, Wild SH, Lamb MJ. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic med j Bri Diabetic Asso. 2015;32:1036-50.

Sainsbury E, Kizirian NV, Partridge SR. Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis. Diabetes rese clin practice. 2018;139:239-52.

Snorgaard O, Poulsen GM, Andersen HK. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ open diabetes res care. 2017;5:e000354.

Huntriss R, Campbell M and Bedwell C. The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Eur j clin nutrition. 2018;72:311-25.

Turton J, Brinkworth GD, Field R. An evidence-based approach to developing low-carbohydrate diets for type 2 diabetes management: A systematic review of interventions and methods. Diabetes, Obesity Metabolism. 2019;21:2513-25.

Tay J, Thompson CH, Luscombe-Marsh ND. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial. Diabetes, obesity metabolism. 2018;20:858-71.

Diabetes Australia. Position Statement: Low carbohydrate eating for people with diabetes. Available at: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/dbd70857-a834-45b0-b6f1-ea2582bbe5c7.pdf. Accessed Jan 03 2019.

Diabetes UK. Position statement: Low-carb diets for people with diabetes. Available at: https://www.diabetes.org.uk/resources-s3/2017-09/low-carb-diets-position-statement-May-2017.pdf. Accessed Mar 21 2019.

Davies MJ, D’Alessio DA, Fradkin J. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669.

Lawton J, Rankin D, Cooke DD. Dose Adjustment for Normal Eating: a qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK. Diabetes res clin practice. 2011;91:87-93.

Buyken AE, Toeller M, Heitkamp G. Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group. Diabetic medicine j Bri Diabetic Association. 2000;17:351-9.

Turton JL, Raab R and Rooney KB. Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review. PLOS ONE. 2018;13:e0194987.

Krebs JD, Parry Strong A, Cresswell P. A randomised trial of the feasibility of a low carbohydrate diet vs standard carbohydrate counting in adults with type 1 diabetes taking body weight into account. Asia Pacific j clin nutrition. 2016;25:78-84.

Schmidt S, Christensen MB, Serifovski N. Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study. Diabetes, obesity metabolism. 2019;21:1680-88.

Piłaciński S and Zozulińska-Ziółkiewicz DA. Influence of lifestyle on the course of type 1 diabetes mellitus. Arch Med Sci. 2014;10:124-34.

Tiwari S, Riazi S and Ecelbarger CA. Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes. Am J Physiology-Renal Physiol. 2007;293:F974-84.

Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet (London, England). 2016;388:465-75.

Krebs JD, Arahill J, Cresswell P. The effect of additional mealtime insulin bolus using an insulin-to-protein ratio compared to usual carbohydrate counting on postprandial glucose in those with type 1 diabetes who usually follow a carbohydrate-restricted diet: A randomized cross-over trial. Diabetes, obesity metabolism. 2018;20:2486-9.

Hallberg SJ, McKenzie AL, Williams PT. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Therapy. 2018;9:583-612.

Murdoch C, Unwin D, Cavan D. Adapting diabetes medication for low carbohydrate management of type 2 diabetes: a practical guide. Br J Gen Pract. 2019;69:360-61.

Burroughs TE, Desikan R, Waterman BM. Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory. Diabetes Spectrum. 2004;17:41-9.

Krebs JD, Arahill J, Cresswell P. The effect of additional mealtime insulin bolus using an insulin-to-protein ratio compared to usual carbohydrate counting on postprandial glucose in those with type 1 diabetes who usually follow a carbohydrate-restricted diet: A randomized cross-over trial. Diabetes, obesity metabolism. 2018;20:2486-9.

Wolever TMS, Chiasson J-L, Josse RG. Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD). Canadian J Diabetes. 2017;41:164-76.

Osler W, McCrae T. The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine. D. Appleton. 1921.

Turton JL, Struik NA, Riley M. Adults with and without type 1 diabetes have similar energy and macronutrient intakes: an analysis from the Australian Health Survey 2011-2013. Nutrition research (New York, NY) 2020; 84: 25-32.

Holmes-Walker DJ, Abraham MB, Chee M. Glycaemic outcomes in Australasian children and adults with Type 1 Diabetes: failure to meet targets across the age spectrum. Int med j. 2021;2021:06-19.

Downloads

Published

2021-07-22